Volume 86, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Home management of malaria is recommended for prompt, effective antimalarial treatment in children less than five years of age. Compliance, safety, and effectiveness of the new fixed-dose artesunate-amodiaquine regimen used to treat suspected malaria were assessed in febrile children enrolled in a 24-month cohort study in two settings in Madagascar. Children with fever were asked to visit community health workers. Presumptive antimalarial treatment was given and further visits were scheduled for follow-up. The primary endpoint was the risk of clinical/parasitologic treatment failure. Secondary outcomes included fever/parasite clearance, change in hemoglobin levels, and frequency of adverse events. The global clinical cure rate was 98.4% by day 28 and 97.9% by day 42. Reported compliance was 83.4%. No severe adverse effects were observed. This study provides comprehensive data concerning the clinical cure rate obtained with artesunate-amodiaquine and evidence supporting the scaling up of home management of malaria.


Article metrics loading...

Loading full text...

Full text loading...



  1. Snow RW, Guerra CA, Mutheu JJ, Hay SI, , 2008. International funding for malaria control in relation to populations at risk of stable Plasmodium falciparum transmission. PLoS Med 5: e142.[Crossref]
  2. Foster S, , 1995. Treatment of malaria outside the formal health services. J Trop Med Hyg 98: 2934.
  3. Kager PA, , 2002. Malaria control: constraints and opportunities. Trop Med Int Health 7: 10421046.[Crossref]
  4. Moerman F, Lengeler C, Chimumbwa J, Talisuna A, Erhart A, Coosemans M, D'Alessandro U, , 2003. The contribution of health-care services to a sound and sustainable malaria-control policy. Lancet Infect Dis 3: 99102.[Crossref]
  5. Wiseman V, Scott A, Conteh L, McElroy B, Stevens W, , 2008. Determinants of provider choice for malaria treatment: experiences from The Gambia. Soc Sci Med 67: 487496.[Crossref]
  6. World Health Organization, 2004. Scaling Up Home-Based Management of Malaria: from Research to Implementation. Geneva: World Health Organization.
  7. World Health Organization, 2005. The Roll Back Malaria Strategy for Improving Access to Treatment through Home Management of Malaria. Geneva: World Health Organization WHO/HTM/MAL/2005.1101.
  8. Greenwood B, Marsh K, Snow R, , 1991. Why do some African children develop severe malaria? Parasitol Today 7: 277281.[Crossref]
  9. D'Alessandro U, Talisuna A, Boelaert M, , 2005. Editorial: Should artemisinin-based combination treatment be used in the home-based management of malaria? Trop Med Int Health 10: 12.[Crossref]
  10. Ratsimbasoa A, Randrianarivelojosia M, Millet P, Soares JL, Rabarijaona L, Rakotoson B, Malvy D, Menard D, , 2006. Use of pre-packaged chloroquine for the home management of presumed malaria in Malagasy children. Malar J 5: 79.[Crossref]
  11. Andriantsoanirina V, Menard D, Tuseo L, Durand R, , 2010. History and current status of Plasmodium falciparum antimalarial drug resistance in Madagascar. Scand J Infect Dis 42: 2232.[Crossref]
  12. Menard D, Ratsimbasoa A, Randrianarivelojosia M, Rabarijaona LP, Raharimalala L, Domarle O, Randrianasolo L, Randriamanantena A, Jahevitra M, Andriantsoanirina V, Rason MA, Raherinjafy R, Rakotomalala E, Tuseo L, Raveloson A, , 2008. Assessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: up-dated baseline data from randomized and multi-site clinical trials. Malar J 7: 55.[Crossref]
  13. Pagnoni F, , 2009. Malaria treatment: no place like home. Trends Parasitol 25: 115119.[Crossref]
  14. Menard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, Ratsimbasoa A, Thonier V, Carod JF, Domarle O, Colin Y, Bertrand O, Picot J, King CL, Grimberg BT, Mercereau-Puijalon O, Zimmerman PA, , 2010. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci USA 107: 59675971.[Crossref]
  15. Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, Allen E, Dlamini SS, Tsoka J, Bredenkamp B, Mthembu DJ, White NJ, Sharp BL, , 2005. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med 2: e330.[Crossref]
  16. Depoortere E, Guthmann JP, Sipilanyambe N, Nkandu E, Fermon F, Balkan S, Legros D, , 2004. Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia. Trop Med Int Health 9: 6267.[Crossref]
  17. Depoortere E, Salvador ET, Stivanello E, Bisoffi Z, Guthmann JP, , 2004. Adherence to a combination of artemether and lumefantrine (Coartem) in Kajo Keji, southern Sudan. Ann Trop Med Parasitol 98: 635637.[Crossref]
  18. World Health Organization, 2003. Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated falciparum Malaria. Geneva: World Health Organization.
  19. World Health Organization, 1996. Management of Uncomplicated Malaria and the Use of Antimalarial Drugs for the Protection of Travellers: Report of an Informal Consultation (WHO/MAL/96). Geneva: World Health Organization.
  20. Mangold KA, Manson RU, Koay ES, Stephens L, Regner M, Thomson RB, Jr Peterson LR, Kaul KL, , 2005. Real-time PCR for detection and identification of Plasmodium spp. J Clin Microbiol 43: 24352440.[Crossref]
  21. Rakotonirina H, Barnadas C, Raherijafy R, Andrianantenaina H, Ratsimbasoa A, Randrianasolo L, Jahevitra M, Andriantsoanirina V, Menard D, , 2008. Accuracy and reliability of malaria diagnostic techniques for guiding febrile outpatient treatment in malaria-endemic countries. Am J Trop Med Hyg 78: 217221.
  22. Cattamanchi A, Kyabayinze D, Hubbard A, Rosenthal PJ, Dorsey G, , 2003. Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. Am J Trop Med Hyg 68: 133139.
  23. Hopkins H, Talisuna A, Whitty CJ, Staedke SG, , 2007. Impact of home-based management of malaria on health outcomes in Africa: a systematic review of the evidence. Malar J 6: 134.[Crossref]
  24. Ajayi IO, Browne EN, Bateganya F, Yar D, Happi C, Falade CO, Gbotosho GO, Yusuf B, Boateng S, Mugittu K, Cousens S, Nanyunja M, Pagnoni F, , 2008. Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: a report from three study sites in sub-Saharan Africa. Malar J 7: 190.[Crossref]
  25. Faucher JF, Aubouy A, Adeothy A, Cottrell G, Doritchamou J, Gourmel B, Houze P, Kossou H, Amedome H, Massougbodji A, Cot M, Deloron P, , 2009. Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated Plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial. J Infect Dis 200: 5765.[Crossref]
  26. Ajayi IO, Browne EN, Garshong B, Bateganya F, Yusuf B, Agyei-Baffour P, Doamekpor L, Balyeku A, Munguti K, Cousens S, Pagnoni F, , 2008. Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites. Malar J 7: 6.[Crossref]
  27. White NJ, , 2004. Antimalarial drug resistance. J Clin Invest 113: 10841092.[Crossref]

Data & Media loading...

  • Received : 21 Jan 2011
  • Accepted : 24 Jun 2011

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error